Crown Bioscience
Latest round
- Series D
Last raised
- May 2014
Total raised
- $77M
Investors
- 13
About Crown Bioscience
Crown Bioscience, Inc.Founded in 2006 and headquartered in Santa Clara, US, Crown Bioscience operates in the oncology field, providing crucial research services.Crown Bioscience is a Contract Research Organization (CRO) specializing in oncology and immuno-oncology drug discovery and development. The company provides a comprehensive suite of preclinical and translational services aimed at supporting biotech and pharmaceutical companies throughout their research and development processes. Its key offerings include innovative in vitro and in vivo models, particularly for hematological malignancies, utilizing their advanced 3D bone marrow niche models.Crown Bioscience generates revenue primarily through service contracts with pharmaceutical and biotechnology clients, structured as B2B transactions. Their business model includes fixed-price contracts, milestone payments, and retainer fees for ongoing research services. Their flagship offerings, including advanced organoid models and preclinical testing services, drive substantial revenue, reflecting a tailored approach to meet specific client needs. Collaborations and partnerships, such as recent extensions with NEXT Oncology, further support the company’s financial stability and growth. Specific strategies include the development of upcoming products designed to improve drug discovery processes, with targeted efforts to broaden their presence in Asia by 2025.
Who invested in Crown Bioscience
13 investors across 6 rounds
See all investors in Crown Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Crown Bioscience
Who invested in Crown Bioscience?
Crown Bioscience has 13 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Crown Bioscience raised?
Crown Bioscience has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Crown Bioscience last raise money?
Crown Bioscience's most recent round on record is a Series D, in May 2014.
What does Crown Bioscience do?
Crown Bioscience is a pharmaceuticals company.
Where is Crown Bioscience headquartered?
Crown Bioscience is headquartered in Santa Clara, US.
Which VCs invest in companies like Crown Bioscience?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Crown Bioscience's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Crown Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.